Page last updated: 2024-08-16

temozolomide and aminolevulinic acid

temozolomide has been researched along with aminolevulinic acid in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Benfenati, E; Raska, I; Toropov, AA; Toropova, AP1
Kern, BC; Krex, D; Mehdorn, HM; Nestler, U; Pichlmeier, U; Stockhammer, F; Stummer, W; Vince, GH1
Arza, C; Díez Valle, R; Galván, J; Romariz, C; Slof, J; Vidal, C1
Buchner, A; Lyu, C; Pohla, H; Schrader, I; Sroka, R; Stadlbauer, B; Stepp, H; Werner, M1
Aboukaïs, R; Bourgeois, P; Devalckeneer, A; Lejeune, JP; Reyns, N1

Trials

1 trial(s) available for temozolomide and aminolevulinic acid

ArticleYear
Favorable outcome in the elderly cohort treated by concomitant temozolomide radiochemotherapy in a multicentric phase II safety study of 5-ALA.
    Journal of neuro-oncology, 2011, Volume: 103, Issue:2

    Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Antineoplastic Agents; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Female; Glioma; Humans; Kaplan-Meier Estimate; Karnofsky Performance Status; Male; Middle Aged; Photosensitizing Agents; Radiotherapy; Temozolomide; Treatment Outcome

2011

Other Studies

4 other study(ies) available for temozolomide and aminolevulinic acid

ArticleYear
QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:4

    Topics: Antineoplastic Agents; Models, Chemical; Octanols; Quantitative Structure-Activity Relationship; Water

2010
Observational, retrospective study of the effectiveness of 5-aminolevulinic acid in malignant glioma surgery in Spain (The VISIONA study).
    Neurologia (Barcelona, Spain), 2014, Volume: 29, Issue:3

    Topics: Aminolevulinic Acid; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Disease-Free Survival; Female; Glioma; Humans; Male; Middle Aged; Neurosurgical Procedures; Photosensitizing Agents; Retrospective Studies; Surgery, Computer-Assisted; Temozolomide; Treatment Outcome

2014
The role of Shikonin in improving 5-aminolevulinic acid-based photodynamic therapy and chemotherapy on glioblastoma stem cells.
    Photodiagnosis and photodynamic therapy, 2022, Volume: 39

    Topics: Aminolevulinic Acid; Brain Neoplasms; Cell Line, Tumor; Glioblastoma; Humans; Naphthoquinones; Neoplasm Recurrence, Local; Photochemotherapy; RNA, Messenger; Temozolomide

2022
Supraorbital transciliary approach as primary route to fronto-basal high grade glioma resection with 5-Aminolevulinic Acid use: Technical note.
    Neuro-Chirurgie, 2023, Volume: 69, Issue:1

    Topics: Aminolevulinic Acid; Brain Neoplasms; Glioblastoma; Glioma; Humans; Neoplasm Recurrence, Local; Temozolomide

2023